中國鐵建(01186.HK):聯交所確認公司可就公路資產進行分拆並於上交所獨立上市
格隆匯6月7日丨中國鐵建(01186.HK)公吿,基礎設施公募REITs建議分拆及於上海證券交易所獨立上市最新進展。公司已就擬分拆公路資產並於上交所獨立上市向聯交所提交第15項應用指引申請。聯交所已確認公司可進行擬分拆。此外,公司亦已申請且聯交所已授出豁免嚴格遵守上市規則第15項應用指引第3(f)段規定。
董事認為,擬分拆將(i)市場化該項目的價值;(ii)為基礎設施建設引入新的權益投資渠道,減少本公司對債務融資的依賴;及(iii)提升本公司形象及商譽;因此,董事會認為,擬分拆能為集團帶來顯着的商業利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.